A61K 2039/10
Brucella
Official title: {Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups}
A61K2039/10 (Brucella) appears on 11 US grants and 22 published applications in this corpus.
Search patents in A61K- Granted patents
- 11
- Published applications
- 22
- Assignees
- 17
- Inventors
- 61
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 1 | 2 |
| 2021 | 4 | 3 |
| 2022 | 0 | 2 |
| 2023 | 1 | 4 |
| 2024 | 2 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fusion protein comprising BP26 and antigenic polypeptide23 Jun 2026US 12,662,515 B2Korea Advanced Institute of Science and Technology
- Liquid applicator for delivering vaccines16 Dec 2025US 12,496,177 B2
- Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same17 Sep 2024US 12,090,195 B2Serum Institute of India Private Limited
- Triterpene saponin analogues16 Jul 2024US 12,037,355 B2Adjuvance Technologies, Inc.
- Liquid applicator for delivering vaccines3 Oct 2023US 11,771,539 B2Boehringer Ingelheim Animal Health USA Inc.
- Liquid Applicator for Delivering Vaccines23 Apr 2026US 2026/0108340 A1Boehringer Ingelheim Animal Health USA Inc.
- Tolerogenic composition1 Jan 2026US 2026/0000744 A1
- Methods of treating or preventing autoimmune diseases4 Sep 2025US 2025/0277223 A1Imcyse SA
- Triterpene saponin analogues3 Oct 2024US 2024/0327443 A1Adjuvance Technologies, Inc.
- Cross-protective antigens for vaccination8 Feb 2024US 2024/0042003 A1West Virginia University Board of Governors on behalf of West Virginia University
Most cited
By later US patents
- Liquid applicator for delivering vaccines9US 11,173,022 B2Boehringer Ingelheim Animal Health USA Inc. · 2021
- Effect of an attenuated Bordetella strain against allergic disease6US 9,415,077 B2Institut National de la Sante et de la Recherche Medicale · 2016
- Triterpene saponin analogues5US 10,906,926 B2Adjuvance Technologies, Inc. · 2021
- Mutant Bordetella strains and methods of use4US 10,682,377 B2Institut National De La SantéEt De La Recherche MéDicale · 2020
- Mutant Bordetella strains and methods of use3US 11,065,276 B22021